Market Overview

Global Biopharmaceutical CMO (Mammalian & Microbial) Market Report 2018-2023 Featuring Lonza, Boehringer Ingelheium, Samsung Biologics & Wuxi Biologics

Share:

Global Biopharmaceutical CMO (Mammalian & Microbial) Market Report 2018-2023 Featuring Lonza, Boehringer Ingelheium, Samsung Biologics & Wuxi Biologics

PR Newswire

DUBLIN, July 24, 2018 /PRNewswire/ --

The "Global Biopharmaceutical CMO Market - Analysis By Region, By Country: Opportunities and Forecast (2018-2023) -- By Region (North America, Europe, APAC), By Country (U.S, Denmark, Germany, Switzerland, Korea, Japan, China)" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo


The global market value is projected to display a steady growth represented by a CAGR of 14.36% during the forecast period of 2018 - 2023.

Amongst the regions, Europe accounts for the largest share by value in global Bio CMO market in 2017. Additionally, Asia Pacific will be a growing region in the forecasted period, 2018-2023 as population is increasing along with growing number of pharmaceutical requirements. Growing number of chronic diseases is also supporting the market of Bio CMO industry.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Bio CMO market. Additionally, the report also assesses the financial performance and strategies of various companies operating in the Biopharmaceutical CMO market.


Scope of the Report




Global Bio CMO Market (Actual Period: 2013-2017, Forecast Period: 2018-2023

  • Global Bio CMO Market - By value
  • By Type - Mammalian & Microbial

Regional Markets - North America, Europe, APAC (Actual Period: 2013-2017, Forecast Period: 2018-2023)

  • Bio CMO Market - By value

Country Analysis - U.S, Denmark, Germany, Switzerland, Korea, Japan, China and Others

  • Bio CMO Market - By value

Other Report Highlights

  • Market Dynamics - Drivers and Restraints
  • Company Analysis - Lonza, Boehringer Ingelheium, Samsung Biologics, Wuxi Biologics

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Biopharmaceutical CMO Market Outlook

4. Global Bio CMO Market: Growth and Forecast

5. Global Biopharmaceutical Market: Segment Analysis

6. North America Bio CMO Market: Growth and Forecast

7. U.S Bio CMO Market, By indications

8. Canada Bio CMO Market , By Indications

9. Europe Bio CMO Market: Growth and Forecast

10. Germany Bio CMO Market, By indications

11. U.K Bio CMO Market, By indications

12. France Bio CMO Market, By indications

13. APAC Bio CMO Market: Growth and Forecast

14. China Bio CMO Market, By indications

15. India Bio CMO Market, By indications

16. Japan Bio CMO Market, By indications

17. Bio CMO Market: Country Analysis

18. Global Bio CMO Market Dynamics

19. Company Profiles

  • Lonza
  • Boehringer Ingelheium
  • Samsung Biologics
  • Wuxi Biologics

For more information about this report visit https://www.researchandmarkets.com/research/rr2vkm/global?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




Cision View original content:http://www.prnewswire.com/news-releases/global-biopharmaceutical-cmo-mammalian--microbial-market-report-2018-2023-featuring-lonza-boehringer-ingelheium-samsung-biologics--wuxi-biologics-300685497.html

SOURCE Research and Markets

View Comments and Join the Discussion!